Synthetic oligonucleotides are an exciting class of therapeutic products that are under development for a variety of indications.Many of them have been deve
The major obstacle to harnessing RNAi for treating cancer is delivering RNAs into disseminated cancer cells.Aptamer-siRNA chimeras (AsiC) are a flexible and